From August 22 to 24, 2025, the "2025 Guangzhou Medical and Health Industry Expo" (hereinafter referred to as Guangzhou Medical Expo), hosted by the People's Government of Guangzhou Municipality and organized by the Guangzhou Municipal Health Commission and the Guangzhou Municipal Cooperation Office, grandly opened in Guangzhou. This expo brought together local leading enterprises such as Guangzhou Pharmaceutical Holdings, Akeso, and KingMed Diagnostics, focusing on showcasing cutting-edge technological achievements including gene editing, cell therapy, and AI + medical testing. KingMed Diagnostics made its appearance with its independently developed Yujian Yiyan Large Model and intelligent application "Xiaoyu Yi", demonstrating the company's "AI IN ALL" panorama to support precise diagnosis and jointly create value-based healthcare.

AI Technology Restructuring the Medical Testing Ecosystem

At the KingMed Diagnostics exhibition area, the Yujian Yiyan Large Model and the intelligent application "Xiaoyu Yi" were the core highlights. They can be applied in scenarios such as clinical diagnosis and treatment, the construction of county-level medical consortia, the development of smart laboratories, health management, and public health prevention and control, serving as AI assistants for diagnosis and treatment beside clinicians and laboratory physicians.

Making Healthcare More Precise and Accessible

Having been deeply engaged in the medical testing industry for over 30 years, KingMed Diagnostics has accumulated a core asset of more than 3 billion medical testing data cases. As a pioneer in the marketization of medical data elements, KingMed Diagnostics took the lead in 2024 to list the first data product, complete on-site transactions of data products, and record data assets in the balance sheet. In July this year, the National Data Administration announced the first batch of pilot list for the innovative development of trusted data spaces, and KingMed Diagnostics was successfully selected, becoming the only medical institution in the medical and health industry to obtain this qualification. This indicates that KingMed Diagnostics' practices in the secure circulation, value mining, and application of medical data have been recognized at the national level, which is also conducive to complementing the integrity of medical testing data and thus exploring more possibilities for data circulation.

During an interview at the Guangzhou Medical Expo, Liu Si, AI Technology Consultant of KingMed Diagnostics, further shared the company's core achievements in digital transformation.

Through this expo, KingMed Diagnostics comprehensively demonstrated its technological layout and industrial practices under the "AI IN ALL" strategy, reflecting the enterprise's solid accumulation and forward-looking exploration in the field of smart medical testing and data innovation.

Partial Source: KingMed Diagnostics.